ATH 10.0% 0.5¢ alterity therapeutics limited

NEW PAPER about ATH434 and endothelial cells !!!!, page-17

  1. 1,494 Posts.
    lightbulb Created with Sketch. 93
    Hi Pivalde,

    im sure Sinclair is pushing this line of research - Alterity is fully aware :


    Funding: This work was carried out with the support of Alterity Therapeutics, Newark, CA to DJK (alteritytherapeutics.com). Alterity provided partial support for Ms. Bailey’s stipend and for supplies required to conduct this research. Further support for the Kosman Lab is provided by grant RO1 NS102337 to DJK from the National Institutes of Health of the United States (www.nih.gov). The funders played no role in the design nor conduct of this research. The contributions to this manuscript provided by Alterity scientific staff are acknowledged as appropriate.

 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢
Change
-0.001(10.0%)
Mkt cap ! $23.60M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $6.104K 1.245M

Buyers (Bids)

No. Vol. Price($)
67 89978820 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 28579695 19
View Market Depth
Last trade - 10.32am 17/06/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.